2014
Mondal SB, Gao S, Zhu N, Liang R, Gruev V, Achilefu S. 2014. Real-time fluorescence image-guided oncologic surgery. Adv Cancer Res. 124:171–211. doi:10.1016/B978-0-12-411638-2.00005-7.
Megaraj V, Zhou X, Xie F, Liu Z, Yang W, Ding X. 2014. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model. Carcinogenesis. 35:131–7. doi:10.1093/carcin/bgt269.
Taverna JA, Babiker HM, Yun S, Bishop MC, Lau-Braunhut S, Meyer PN, Enzler T. 2014. The great masquerader of malignancy: chronic intestinal pseudo-obstruction. Biomark Res. 2:23. doi:10.1186/s40364-014-0023-y.
2013
Larsen BT, Bishop MC, Hunter GC, Renner SW. 2013. Low-grade, metastasizing splenic littoral cell angiosarcoma presenting with hepatic cirrhosis and splenic artery aneurysm. Int J Surg Pathol. 21:618–26. doi:10.1177/1066896913476737.
Loescher LJ, Hansen C, Hepworth JT, Quale L, Sligh J. 2013. A preliminary study of a video intervention to inform solid organ transplant recipients about skin cancer. Transplant Proc. 45:3187–9. doi:10.1016/j.transproceed.2012.09.118.
Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, Glass CK. 2013. Effect of natural genetic variation on enhancer selection and function. Nature. 503:487–92. doi:10.1038/nature12615.
Hart MR, Su H-Y, Broka D, Goverdhan A, Schroeder JA. 2013. Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression. Mol Ther. 21:1996–2007. doi:10.1038/mt.2013.196.
Klebba JE, Buster DW, Nguyen AL, Swatkoski S, Gucek M, Rusan NM, Rogers GC. 2013. Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron. Curr Biol. 23:2255–2261. doi:10.1016/j.cub.2013.09.019.
Tula-Sanchez AA, Havas AP, Alonge PJ, Klein ME, Doctor SR, Pinkston W, Glinsmann-Gibson BJ, Rimsza LM, Smith CL. 2013. A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors. Cancer Biol Ther. 14:949–61. doi:10.4161/cbt.25941.
Kadiyala V, Patrick NM, Mathieu W, Jaime-Frias R, Pookhao N, An L, Smith CL. 2013. Class I lysine deacetylases facilitate glucocorticoid-induced transcription. J Biol Chem. 288:28900–12. doi:10.1074/jbc.M113.505115.
Sugeng AJ, Beamer PI, Lutz EA, Rosales CB. 2013. Hazard-ranking of agricultural pesticides for chronic health effects in Yuma County, Arizona. Sci Total Environ. 463-464:35–41. doi:10.1016/j.scitotenv.2013.05.051.
Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. 2013. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol. 24:2506–14. doi:10.1093/annonc/mdt224.
Bean MG, Stone J, Moskowitz GB, Badger TA, Focella ES. 2013. Evidence of nonconscious stereotyping of Hispanic patients by nursing and medical students. Nurs Res. 62:362–7. doi:10.1097/NNR.0b013e31829e02ec.
Harris DT. 2013. Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications. Curr Stem Cell Res Ther. 8:394–9. doi:10.2174/1574888x11308050006.
Bell ML, McKenzie JE. 2013. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psychooncology. 22:1738–47. doi:10.1002/pon.3205.
Nagle RB, Algotar AM, Cortez CC, Smith K, Jones C, Sathyanarayana UG, Yun S, Riley J, Nagy D, Dittamore R, et al. 2013. ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma. Prostate. 73:1233–40. doi:10.1002/pros.22675.
Bowen C, Ju J-H, Lee J-H, Paull TT, Gelmann EP. 2013. Functional activation of ATM by the prostate cancer suppressor NKX3.1. Cell Rep. 4:516–29. doi:10.1016/j.celrep.2013.06.039.
Cooley JH, Quale LM. 2013. Skin cancer preventive behavior and sun protection recommendations. Semin Oncol Nurs. 29:223–6. doi:10.1016/j.soncn.2013.06.008.
Belzer M, Morales M, Jagadish B, Mash EA, Wright SH. 2013. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther. 346:300–10. doi:10.1124/jpet.113.203257.
Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. 2013. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. Eur J Pharm Sci. 49:699–711. doi:10.1016/j.ejps.2013.05.012.
Badger T, Segrin C, Pasvogel A, López AM. 2013. The effect of psychosocial interventions delivered by telephone and videophone on quality of life in early-stage breast cancer survivors and their supportive partners. J Telemed Telecare. 19:260–5. doi:10.1177/1357633X13492289.
Cen B, Mahajan S, Wang W, Kraft AS. 2013. Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1. Cancer Res. 73:3402–11. doi:10.1158/0008-5472.CAN-12-4619.
Zhang J, Chen QM. 2013. Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene. 32:2907–16. doi:10.1038/onc.2012.350.
Miller JA, Lang JE, Ley M, Nagle R, Hsu C-H, Thompson PA, Cordova C, Waer A, Chow H-HS. 2013. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila). 6:577–84. doi:10.1158/1940-6207.CAPR-12-0452.
Woo H-H, Baker T, Laszlo C, Chambers SK. 2013. Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA. Mol Cell Proteomics. 12:1661–77. doi:10.1074/mcp.M112.025288.